Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.7834
+0.0323 (4.31%)
Feb 27, 2026, 4:00 PM EST - Market closed
Vaxart Market Cap
Vaxart has a market cap or net worth of $187.99 million as of February 27, 2026. Its market cap has increased by 55.36% in one year.
Market Cap
187.99M
Enterprise Value
181.33M
1-Year Change
55.36%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since December 1, 1998, Vaxart's market cap has increased from $89.40M to $187.99M, an increase of 110.28%. That is a compound annual growth rate of 2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 73.00M | -51.53% |
| Dec 31, 2024 | 150.60M | 72.90% |
| Dec 29, 2023 | 87.10M | -30.93% |
| Dec 30, 2022 | 126.10M | -83.98% |
| Dec 31, 2021 | 786.90M | 25.88% |
| Dec 31, 2020 | 625.10M | 3,643.11% |
| Dec 31, 2019 | 16.70M | 24.63% |
| Dec 31, 2018 | 13.40M | -38.81% |
| Dec 29, 2017 | 21.90M | -53.89% |
| Dec 30, 2016 | 47.50M | -36.67% |
| Dec 31, 2015 | 75.00M | -4.58% |
| Dec 31, 2014 | 78.60M | -33.84% |
| Dec 31, 2013 | 118.80M | 531.91% |
| Dec 31, 2012 | 18.80M | -76.67% |
| Dec 30, 2011 | 80.60M | -67.21% |
| Dec 31, 2010 | 245.80M | -1.17% |
| Dec 31, 2009 | 248.70M | 42.93% |
| Dec 31, 2008 | 174.00M | -21.20% |
| Dec 31, 2007 | 220.80M | -46.13% |
| Dec 29, 2006 | 409.90M | 104.24% |
| Dec 30, 2005 | 200.70M | -76.55% |
| Dec 31, 2004 | 855.90M | 44.31% |
| Dec 31, 2003 | 593.10M | 147.13% |
| Dec 31, 2002 | 240.00M | -38.92% |
| Dec 31, 2001 | 392.90M | 125.03% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 193.28M |
| Sagimet Biosciences | 193.18M |
| Fate Therapeutics | 192.06M |
| NeOnc Technologies Holdings | 188.90M |
| Molecular Partners AG | 188.55M |
| Karyopharm Therapeutics | 186.37M |
| Tonix Pharmaceuticals Holding | 185.00M |
| Canton Strategic Holdings | 183.02M |